SCHEMBL10072244

SCHEMBL10072244

CC(C)COC(C)ONC(=O)/C=C/c1ccc(CN[C@](C)(CC(C)C)C(=O)OC2CCOC2)cc1

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
TRPV1 Q8NER1 1/20 0.33
ALDH1A1 P00352 2/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
HDAC3 O15379 1/20 0.31
HDAC4 P56524 1/20 0.31
HDAC1 Q13547 1/20 0.31
HDAC8 Q9BY41 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31
HDAC5 Q9UQL6 1/20 0.31
CCR2 P41597 2/20 0.30
MAPT P10636 2/20 0.30
GAA P10253 1/20 0.30
MAPK1 P28482 1/20 0.30
KDM1A O60341 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9894807 0.90 SMN1; SMN2 (0.37) SMN1; SMN2NPC1RAB9ATRPV1ALDH1A1
SCHEMBL7897085 0.90 SMN1; SMN2 (0.37) SMN1; SMN2NPC1RAB9ATRPV1ALDH1A1
SCHEMBL9894806 0.90 SMN1; SMN2 (0.37) SMN1; SMN2NPC1RAB9ATRPV1ALDH1A1
SCHEMBL9896186 0.90 SMN1; SMN2 (0.37) SMN1; SMN2NPC1RAB9ATRPV1ALDH1A1
SCHEMBL2705563 0.88 HDAC1 (0.41) SMN1; SMN2NPC1RAB9AHDAC3HDAC4
SCHEMBL10072246 0.88 HDAC1 (0.41) SMN1; SMN2NPC1RAB9AHDAC3HDAC4
SCHEMBL2705567 0.88 HDAC1 (0.41) SMN1; SMN2NPC1RAB9AHDAC3HDAC4
SCHEMBL15377011 0.84 SMN1; SMN2 (0.38) SMN1; SMN2NPC1RAB9ATRPV1ALDH1A1
SCHEMBL15377012 0.84 SMN1; SMN2 (0.38) SMN1; SMN2NPC1RAB9ATRPV1ALDH1A1
SCHEMBL7896015 0.84 SMN1; SMN2 (0.38) SMN1; SMN2NPC1RAB9ATRPV1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012025701-A1 ALPHA, ALPHA - DI SUBSTITUTED GLYCINE ESTER DERIVATIVES AND THEIR USE AS HDAC INHIBITORS CHROMA THERAPEUTICS LTD. (GB) 2012-03-01 WO disclosed